Caplight Directory>Companies>SPR Therapeutics-preview>Spr-therapeutics


SPR Therapeutics

SPR Therapeutics

Private
Cleveland, OhioHealthcare & Life Scienceswww.sprtherapeutics.com

Last Round

Series D

Feb 1, 2024

Total Funding Raised

$105.8M

Company Overview

SPR Therapeutics is a medical technology company that develops a peripheral nerve stimulation therapy platform aimed at providing a non-narcotic, safe, and effective alternative for managing severe acute and chronic pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

peripheral nerve stimulationPNSnon-opioid pain managementpain relief deviceopioid alternativeneurostimulationminimally invasive pain treatmentchronic pain treatmentacute pain treatmentSPRINT PNS System60-day pain treatmentimplant-free pain reliefdrug-free pain reliefpost-surgical painpercutaneous nerve stimulationoccipital nerve stimulationDoD contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SPR Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SPR Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DFeb 1, 2024
Series DOct 18, 2021
GrantOct 2, 2018
Series CSep 12, 2017
Convertible DebtAug 25, 2015
Series A
Jan 8, 2013
View all Funding Rounds

SPR Therapeutics Investors

Notable investors and investment history

InvestorRounds
SLR Capital PartnersSeries D
Mutual Capital PartnersSeries D
U.S. Department of DefenseGrant
Rc-bac.comSeries D
NDI Healthcare FundSeries A
River Cities CapitalSeries D
U.S. ArmyGrant
View all Investors

SPR Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SPR Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SPR Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio
Year Founded2010
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.